Citigroup’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $427K | Sell |
123,393
-136,920
| -53% | -$474K | ﹤0.01% | 3022 |
|
|
2025
Q1 | $682K | Buy |
260,313
+54,637
| +27% | +$143K | ﹤0.01% | 2785 |
|
|
2024
Q4 | $847K | Buy |
205,676
+118,290
| +135% | +$487K | ﹤0.01% | 2700 |
|
|
2024
Q3 | $619K | Buy |
87,386
+43,796
| +100% | +$310K | ﹤0.01% | 2861 |
|
|
2024
Q2 | $284K | Sell |
43,590
-371,387
| -89% | -$2.42M | ﹤0.01% | 2999 |
|
|
2024
Q1 | $3.44M | Buy |
414,977
+268,714
| +184% | +$2.23M | ﹤0.01% | 1471 |
|
|
2023
Q4 | $1.61M | Sell |
146,263
-24,821
| -15% | -$273K | ﹤0.01% | 1810 |
|
|
2023
Q3 | $1.44M | Sell |
171,084
-30,622
| -15% | -$258K | ﹤0.01% | 1675 |
|
|
2023
Q2 | $2.53M | Sell |
201,706
-154,406
| -43% | -$1.94M | ﹤0.01% | 1513 |
|
|
2023
Q1 | $5.87M | Buy |
356,112
+146,872
| +70% | +$2.42M | ﹤0.01% | 1050 |
|
|
2022
Q4 | $3.13M | Buy |
209,240
+27,462
| +15% | +$410K | ﹤0.01% | 1271 |
|
|
2022
Q3 | $4.07M | Sell |
181,778
-4,380
| -2% | -$98K | ﹤0.01% | 1204 |
|
|
2022
Q2 | $3.12M | Buy |
186,158
+154,898
| +496% | +$2.59M | ﹤0.01% | 1317 |
|
|
2022
Q1 | $936K | Sell |
31,260
-128,355
| -80% | -$3.84M | ﹤0.01% | 2408 |
|
|
2021
Q4 | $4.9M | Buy |
159,615
+25,382
| +19% | +$780K | ﹤0.01% | 1298 |
|
|
2021
Q3 | $4.23M | Buy |
134,233
+11,007
| +9% | +$347K | ﹤0.01% | 1396 |
|
|
2021
Q2 | $4.51M | Buy |
123,226
+15,312
| +14% | +$560K | ﹤0.01% | 1500 |
|
|
2021
Q1 | $3.73M | Buy |
107,914
+98,096
| +999% | +$3.39M | ﹤0.01% | 1537 |
|
|
2020
Q4 | $408K | Buy |
9,818
+8,272
| +535% | +$344K | ﹤0.01% | 2765 |
|
|
2020
Q3 | $66K | Buy |
+1,546
| New | +$66K | ﹤0.01% | 3346 |
|